Last 24 Hours March 05, 2026 — 57 articles reviewed This cycle’s coverage centered on reassuring longitudinal data about cannabis and cognitive aging in older adults, mounting evidence that THC blood levels...
Study Links Rising Cannabis Use to Poor Mental Health – U.S. News & World Report
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. Mental HealthResearchAgingSafety Why This Matters Clinicians need to be aware that cannabis use in older...
Study: Lifetime Cannabis Use Not Associated with Cognitive Decline or Dementia Risk in … – NORML
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchNeurologyAgingSafety Why This Matters Clinicians counseling older adults about cannabis safety can now reference prospective...
Washington Senators Approve Bill To Let Terminally Ill Patients Use Medical Cannabis In Hospitals
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyCancerSafety Why This Matters This policy directly impacts end-of-life care by enabling clinicians to accommodate...
Daily Digest: Last 18 Hours: Cannabis Impairment Testing, Brain Aging, and the Race for Better Evidence — March 05, 2026
A synthesis of 6 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.
Daily Digest: Last 19 Hours: Aging Brains, Adolescent Risk, and the Slow March of Policy Reform — March 04, 2026
A synthesis of 53 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.
West Virginia House approves bill allowing medical cannabis edibles | WV News
WHY IT MATTERS: West Virginia medical cannabis patients who previously had limited delivery options may soon be able to access edible formulations, giving physicians and patients more tools to tailor treatment to individual medical needs. CLINICAL OVERVIEW: West Virginia’s expansion of its medical cannabis program to include edible formulations represents a meaningful step toward improving patient access and treatment flexibility. Edibles offer distinct pharmacokinetic advantages for certain patient populations, particularly those with respiratory conditions who cannot tolerate inhalation, or those requiring longer-duration symptom relief due to the slower onset and extended duration of orally administered cannabinoids.
Cannabis Use and Brain Aging: What a Major Study Reveals – Born2Invest
WHY IT MATTERS: Patients who use cannabis regularly and are concerned about long-term brain health now have large-scale data to discuss with their physician, though the findings underscore the importance of individualized conversations rather than blanket reassurance or alarm. CLINICAL OVERVIEW: Research drawing on large biobank datasets has examined whether cannabis use is associated with measurable changes in brain aging trajectories. The findings suggest a nuanced picture in which cannabis users may show some initial differences in brain age metrics, but the relationship between cannabis exposure and long-term neurological aging is not straightforwardly harmful or protective.
Daily Digest: Last 48 Hours: Adolescent Risk, Aging Brains, and the Long Road to Pharmaceutical-Grade Cannabis — March 04, 2026
A synthesis of 53 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.
Daily Digest: Last 24 Hours: Adolescent Risk, Aging Brains, and the Slow March Toward Pharmaceutical-Grade Cannabis — March 04, 2026
Last 24 Hours March 04, 2026 — 41 articles reviewed This cycle’s coverage clustered around two poles of the age spectrum, with a single study in Pediatrics reinforcing that even infrequent adolescent...